BEAM BEAM THERAPEUTICS INC
2026Q1 · CUSIP 07373V105 · Sector: Healthcare & Biotech
Cooling · Breadth rolling over
Holders
248
Δ holders QoQ
+4
Breadth percentile
Top 46%
Whale holders
117
Δ whales
-2
Inst. holding value
$2.6B
New positions
56
Closed positions
52
Price momentum (1Q)
-2.5%
Put / Call
6/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 19% | -2.5% | — |
| 2024Q1 | Top 8% | +1.5% | -2.3% |
| 2022Q3 | Top 6% | -9.7% | -27.7% |
| 2021Q2 | Top 12% | -9.6% | -33.6% |
| 2021Q1 | Top 4% | +47.4% | +33.2% |
| 2020Q4 | Top 7% | -34.3% | -3.1% |
| 2020Q3 | Top 19% | +180.1% | +91.3% |
Options Sentiment
Put holders
6
QoQ: +1
Call holders
6
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.49
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+158.0%
Net margin
-40.2%
ROE
-5.7%
Debt ratio
21.4%
FCF (TTM)
-$384M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.